CALL FOR ESSENTIAL MEDICINES TO BE FREE IN GERMANY
Drugs which are indispensable for patients should be free, according to the German federation of industrial health funds, the BKK, so that chronically sick people are free of financial burdens.
The BKK is proposing that the drug market should be divided into three categories of drug provision - essential drugs, drugs about which there is no argument as to efficacy, safety and significance, and other drug products.
The BKK says that in the case of the non-controversial products, the current 10% patient contribution should be maintained. Other drugs, which will not be included in the positive list of prescription drugs from 1996, should remain prescribable but prescriptions should be based on a medical case being made out by the doctor. In such cases, the BKK suggests, the drugs would be reimbursable.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze